BridgeBio Pharma Inc (NASDAQ:BBIO)

BATS BZX Real-Time Price
As of 3:48pm ET
 +0.12 / +0.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for BridgeBio Pharma Inc have a median target of 82.00, with a high estimate of 91.00 and a low estimate of 66.00. The median estimate represents a +105.15% increase from the last price of 39.97.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in BridgeBio Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.84%
Growthannually 3.30%


Growthquarterly 820.51%
Growthannually 853.96%
Key to the earnings and sales forecast charts.